Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies - Attwood, S E; Ell, C; Galmiche, J P (Alimentary Pharmacology & Therapeutics, 2015)
et al.